Join
Live feed
·
INSIDERFilingvia Quantisnow
Mural Oncology plc logo

Keson-Brookes Maiken was granted 16,800 units of Ordinary Shares, increasing direct ownership by 58% to 46,007 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
MURA· Mural Oncology plc
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MURA (Mural Oncology plc) and more on Quantisnow.